Litigation Details for Pfizer Inc. v. Cipla Limited (D. Del. 2023)
✉ Email this page to a colleague
Pfizer Inc. v. Cipla Limited (D. Del. 2023)
| Docket | ⤷ Try a Trial | Date Filed | 2023-08-18 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory B. Williams |
| Jury Demand | None | Referred To | Christopher J. Burke |
| Parties | WYETH LLC | ||
| Patents | 9,770,441 | ||
| Attorneys | Jack B. Blumenfeld | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pfizer Inc. v. Cipla Limited
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Pfizer Inc. v. Cipla Limited (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-08-18 | 1 | Complaint | prior to the expiration of U.S. Patent No. 9,770,441 (“the ’441 patent”) (attached as Exhibit A). …1. This is an action for patent infringement under the patent laws of the United States, Title…declaratory judgment of patent infringement under 28 U.S.C. §§ 2201 and 2202 and the patent laws of the United… the ’441 patent in the event that Cipla’s ANDA Product is approved before the ’441 patent expires. …’441 patent. 26. Plaintiffs together own all substantial rights in the ’441 patent. | External link to document |
| 2023-08-18 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,770,441 B2. (mpb) (Entered:… 18 August 2023 1:23-cv-00909 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
